Skip Navigation



Carcinogenesis Advance Access published online on April 7, 2005

Carcinogenesis, doi:10.1093/carcin/bgi088
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/8/1422    most recent
bgi088v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Slattery, M. L.
Right arrow Articles by Wolff, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slattery, M. L.
Right arrow Articles by Wolff, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oupjournals.org
Received January 25, 2005
Revised March 11, 2005
Accepted March 25, 2005

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Associations between ApoE genotype and colon and rectal cancer

Martha L. Slattery 1*, Carol Sweeney 1, Maureen Murtaugh 1, Khe Ni Ma 1, John D. Potter 2, Theodore R. Levin 3, Wade Samowitz 4, and Roger Wolff 1

1 Health Research Center, University of Utah, Salt Lake City, Utah 84108
2 Fred Hutchinson Cancer Research Center, Seattle, Washington
3 Kaiser Permanente Medical Care Research Program
4 Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah

* To whom correspondence should be addressed.
Martha L. Slattery, E-mail: mslatter{at}hrc.utah.edu


   Abstract

Apolipoprotein E (apoE) plays a major role in the metabolism of bile acids, cholesterol, and triglycerides and has recently been proposed as being involved in the carcinogenic process. Given the potential role of bile acids in colorectal cancer etiology, it is reasonable that colorectal cancer risk might be modified by apoE genotype. We used data collected from a case-control study of colon cancer (n = 1556 cases and 1948 controls) and rectal cancer (n = 777 cases and 988 controls). Not having an e3 apoE allele significantly increased risk of colon cancer (OR 1.37 95% CI 1.00-1.87), particularly among those diagnosed when older than 64 years (OR = 1.88 95% CI 1.17, 3.04; p interaction between age and apoE genotype 0.05). A significant three-way interaction was detected for family history of colorectal cancer, age at diagnosis and apoE genotype (p = 0.05), with those diagnosed when older and not having an e3 allele having a significant increased risk with family history of colorectal cancer (OR 3.93 95% CI 1.23, 12.6). This compared with risk associated with family history of colorectal cancer among those diagnosed when older with an e3 allele of 1.61 (95% CI 1.17, 2.23) or those diagnosed when younger without an e3 allele (OR 2.40 95% CI 0.56-10.3). Among those diagnosed when older than 64, associations of BMI and prudent diet with colon cancer were stronger among individuals without an e3 allele, although the p for interaction was not significant. We did not detect any significant associations between apoE genotype and rectal cancer, survival after diagnosis with colorectal cancer, stage of disease at diagnosis, or type of tumor mutation. These findings suggest those apoE genotypes that do not include the e3 allele, the same genotypes that are associated with increased risk of coronary heart disease, may influence development of colon cancer among those who are older at diagnosis.

Keywords: apoE; body size; colorectal cancer; diet; lifestyle.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JRSMHome page
G. D. Smith
Capitalizing on Mendelian randomization to assess the effects of treatments
J R Soc Med, September 1, 2007; 100(9): 432 - 435.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.